The Emergence of the Metabolic Syndrome with Menopause
The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
Women with the metabolic syndrome (central obesity, insulin resistance, and dyslipidemia) are known to be at especially high risk for cardiovascular disease (CVD). The prevalence of the metabolic syndrome increases with menopause and may partially explain the apparent acceleration in CVD after menopause. The transition from pre- to postmenopause is associated with the emergence of many features of the metabolic syndrome, including 1) increased central (intraabdominal) body fat; 2) a shift toward a more atherogenic lipid profile, with increased low density lipoprotein and triglycerides levels, reduced high density lipoprotein, and small, dense low density lipoprotein particles; 3) and increased glucose and insulin levels. The emergence of these risk factors may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency. It is unclear whether the transition to menopause increases CVD risk in all women or only those who develop features of the metabolic syndrome. This article will review the features of the metabolic syndrome that emerge with estrogen deficiency. A better understanding of these metabolic changes with menopause will aid in the recognition and treatment of women at risk for future CVD, leading to appropriate interventions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disturbances of this metabolic signal lead to the development of metabolic syndrome and a higher cardiovascular risk in women.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [31]
Citations
Cites
3 retracted
Changes in energy balance and body composition at menopause: a controlled longitudinal study.
Poehlman, E. T., Toth, M. J., & Gardner, A. W. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-9-199511010-00005 · Cited by 520 · cited 4×
“Several groups have shown increased fasting insulin (22, 48) and increased fasting glucose levels (37, 63) in postmenopausal compared with premenopausal women, which would imply worsened insulin resistance with the menopause.”
BackgroundInfluentialRetractedMenopause, energy expenditure, and body composition
Poehlman, E. T. (2002) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.2002.810705.x · Cited by 137 · cited 1×
“Menopause is also associated with reduced lean body mass (muscle) and this appears to be related to decreased physical activity (36).”
BackgroundRetractedPoehlman, É. T., Toth, M., Ades, P. A., & Rosen, C. J. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1160662.x · Cited by 128 · cited 4×
“sociated with weight gain, most studies do not reveal increases in BMI independent of normal aging (23, 24).”
BackgroundInfluentialRetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154 · cited 1×
“Although syndrome X was initially coined by Gerald Reaven in 1988 (16), the features of the metabolic syndrome were first described by Vague (17) and have subsequently been called the insulin resistance syndrome, the central obesity syndrome, and the deadly quartet.”
BackgroundThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033 · cited 1×
“The metabolic syndrome may not be a single disease entity, but, rather, a constellation of closely related risk factors that together convey substantially increased cardiovascular risk after accounting for traditional CVD risk factors (12).”
BackgroundPark, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 3×
“The metabolic syndrome is estimated to affect approximately 20–30% of the middle-aged population (10), and prevalence appears to be increasing in the U.”
BackgroundInfluentialChambless, L. E., Heiss, G., Folsom, A. R., Rosamond, W., Szklo, M., Sharrett, A. R., & Clegg, L. X. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009302 · Cited by 1,990
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Cited by
Items 401–500 of 1,001
Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period
Teixeira, C. J., Veras, K. M. D. A., & Carvalho, C. R. D. O. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01842-5 · Cited by 33
Triglyceride-Glucose Index is a Risk Marker of Incident COPD Events in Women
Zaigham, S., Tanash, H. A., Nilsson, P. M., & Muhammad, I. F. (2022) · International Journal of COPD · doi:10.2147/copd.s360793 · Cited by 32
“Oestrogen elicits a protective effect on insulin resistance by promoting insulin sensitivity and an increase in insulin resistance and the MetS is seen in post-menopausal women, increasing the CVD risk.(36) However, the association with COPD in these women seems to be less clear,(37) therefore it is unlikely that this…”
ResultEstrogen-like activity of aqueous extract from Agrimonia pilosa Ledeb. in MCF-7 cells
Lee, Y. M., Kim, J. B., Bae, J. H., Lee, J. S., Kim, P.-S., Jang, H., & Kim, H.-R. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-260 · Cited by 32
“Postmenopausal women also exhibit a dramatic increase in the risk of metabolic syndrome, cognitive deficits, cardiovascular disease, dyslipidemia, and osteoporosis [2-5].”
BackgroundZhang, H., & Sairam, M. R. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0002 · Cited by 33
“Clinical studies have indicated that postmenopausal status is associated with a 60% increase in MetS [28].”
BackgroundRelation with HOMA-IR and thyroid hormones in obese Turkish women with metabolic syndrome
Topsakal, Ş., Yerlikaya, E., Akın, F., Kaptanoğlu, B., & Öztürk, T. E. (2012) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/bf03325329 · Cited by 32
Ovarian Hormones Regulate the Production of Adipocytes From Bone Marrow-Derived Cells
Gavin, K. M., Sullivan, T. M., Kohrt, W. M., Majka, S. M., & Klemm, D. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00276 · Cited by 33
Janiszewski, P. M., Kuk, J. L., & Ross, R. (2008) · Diabetologia · doi:10.1007/s00125-008-1058-0 · Cited by 36
“Fourth, our study included only premenopausal women, which eliminates the established confounding effects of menstrual status on regional body composition and cardiometabolic risk [41].”
BackgroundKim, J., Im, J., & Lee, D. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31823a3e46 · Cited by 36
Udo, T., Vásquez, E., & Shaw, B. A. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.008 · Cited by 32
Yonekura, Y., Terauchi, M., Hirose, A., Odai, T., Kato, K., & Miyasaka, N. (2020) · Nutrients · doi:10.3390/nu12051370 · Cited by 32
Yang, H. J., Suh, P. S., Kim, S. J., & Lee, S. Y. (2015) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.15.021 · Cited by 36
“Thus, the impact of menopause on women’s health has become more significant from both clinical and health perspectives [1-3].”
BackgroundPighon, A., Paquette, A., Barsalani, R., Chapados, N. A., Yasari, S., Doucet, É., & Lavoie, J.-M. (2009) · Climacteric · doi:10.1080/13697130802447074 · Cited by 35
Kang, Y. G., Suh, E., Chun, H., Kim, S., Kim, D. K., & Bae, C. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s123316 · Cited by 31
“This rise in prevalence is known to be due to the increase of chronic diseases such as central obesity, hypertension, diabetes, dyslipidemia, and deficiency in sex hormones with increasing age.(23,24) Thus, this study aimed to propose a model for MS BA which can be utilized in both the medical fields and ubiquitous he…”
Clookey, S. L., Welly, R. J., Shay, D. A., Woodford, M. L., Fritsche, K. L., Rector, R. S., Padilla, J., Lubahn, D. B., & Vieira‐Potter, V. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00009 · Cited by 34
Miyatani, Y., Yasui, T., Uemura, H., Yamada, M., Matsuzaki, T., Kuwahara, A., Tsuchiya, N., Yuzurihara, M., Kase, Y., & Irahara, M. (2008) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e31815c85ed · Cited by 32
Estrogen Receptors: Their Actions and Functional Roles in Health and Disease
Nilsson, S. V., & Gustafsson, J.-Α. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_5 · Cited by 36
“Decline in estrogen levels as a natural consequence of aging may be associated with dysregulation of lipid and glucose metabolism [324].”
BackgroundClinical correlates of sex hormones in women: The study of health in Pomerania
Kische, H., Groß, S., Wallaschofski, H., Völzke, H., Dörr, M., Nauck, M. A., & Haring, R. (2016) · Metabolism · doi:10.1016/j.metabol.2016.05.011 · Cited by 32
Physical Activity and Reduced Intra‐abdominal Fat in Midlife African‐American and White Women
Dugan, S. A., Everson‐Rose, S. A., Karavolos, K., Avery, E., Wesley, D., & Powell, L. H. (2009) · Obesity · doi:10.1038/oby.2009.396 · Cited by 33
Fu, C.-H., Yang, C. C. H., Lin, C.-L., & Kuo, T. B. J. (2008) · PubMed · Cited by 30
Tung, Y., Hsu, Y.-J., Chien, Y., Huang, C., Huang, W.-C., & Chiu, W. (2019) · Molecules · doi:10.3390/molecules24050980 · Cited by 30
“The OVX mice exhibited metabolic disorders associated with estrogen deficiency, including elevated fasting blood glucose and obesity [3,40,45].”
BackgroundShen, H., Yang, C., Kung, C.-W., Chen, S., Wu, H., Cheng, P., Lam, K., & Lee, Y. (2019) · Journal of Biomedical Science · doi:10.1186/s12929-019-0556-3 · Cited by 34
You, M., Liu, Y., Chen, Y., Pan, Y., Miao, Z., Shi, Y., Si, J., Chen, M., & Hu, F. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13138 · Cited by 32
Shanely, R. A., Zwetsloot, J. J., Jurrissen, T. J., Hannan, L., Zwetsloot, K. A., Needle, A. R., Bishop, A. E., Wu, G., & Perkins-Veazie, P. M. (2020) · Nutrition Research · doi:10.1016/j.nutres.2020.02.005 · Cited by 31
Rondini, E. A., Ramseyer, V. D., Burl, R. B., Piqué-Regi, R., & Granneman, J. G. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101307 · Cited by 30
Hormonal factors and respiratory health in women – a review
Real, F. G., Svanes, C., Macsali, F., & Omenaas, E. R. (2008) · The Clinical Respiratory Journal · doi:10.1111/j.1752-699x.2008.00093.x · Cited by 31
“In addition, women in the perimenopausal transition become more insulin resistant (5), with increasing risk for cardiovascular diseases (6, 7).”
BackgroundJiang, M., He, J., Kucera, H., Gaikwad, N. W., Zhang, B., Xu, M., O'Doherty, R. M., Selcer, K. W., & Xie, W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.535914 · Cited by 31
Cardiovascular Disease and Primary Ovarian Insufficiency
Wellons, M. (2011) · Seminars in Reproductive Medicine · doi:10.1055/s-0031-1280918 · Cited by 31
“Carr’s article, ‘‘The Emergence of the Metabolic Syndrome with Menopause,’’ is a good overview of the complexity of this topic.(69) In addition, a recent publication by Matthews et al from the SWAN cohort provides information on glucose and insulin in women transitioning through a natural menopause at normal ages.”
Campos-Shimada, L. B., Gilglioni, E. H., Garcia, R. F., Brito, M. D. N., Natali, M. R. M., Ishii‐Iwamoto, E. L., & Salgueiro‐Pagadigorria, C. L. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.043 · Cited by 34
Cardiovascular aspects of menopausal hormone replacement therapy
Rosano, G. M. C., Vitale, C., & Fini, M. (2009) · Climacteric · doi:10.1080/13697130903012306 · Cited by 30
Iñigo, M. R., Amorese, A. J., Tarpey, M. D., Balestrieri, N. P., Jones, K. G., Patteson, D. J., Jackson, K. C., Torres, M. J., Lin, C.-T., Smith, C. D., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2019.12.010 · Cited by 29
Lee, J. I., Yu, J. H., Anh, S. G., Lee, H. W., Jeong, J., & Lee, K. S. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0370 · Cited by 31
“Postmenopausal women undergo metabolic changes, including visceral fat accumulation, dyslipidemia, and glucose intolerance, that are associated with insulin resistance and development of NAFLD [11, 12].”
BackgroundEvaluation and management of blood lipids through a woman's life cycle
Sharma, J., McAlister, J., Aggarwal, N. R., Wei, J., Mehta, P. K., Quesada, O., Mattina, D. J., Scott, N. S., Michos, E. D., Mahmoud, Z., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100333 · Cited by 35
“This increases the risk of development of the metabolic syndrome and produces a surge in the secretion of apo B-containing particles, as well as an amplified activity of hepatic lipase, resulting in an increase in LDL-like particles and decrease in HDL-C levels, respectively [53].”
BackgroundAssociation between salivary pH and metabolic syndrome in women: a cross-sectional study
Tremblay, M., Brisson, D., & Gaudet, D. (2012) · BMC Oral Health · doi:10.1186/1472-6831-12-40 · Cited by 29
“This may be a direct result of ovarian failure or, alternatively, an indirect result of the metabolic consequences of central fat redistribution with estrogen deficiency [3].”
BackgroundGloy, V., Langhans, W., Hillebrand, J. J., Geary, N., & Asarian, L. (2011) · Biology of Sex Differences · doi:10.1186/2042-6410-2-6 · Cited by 30
“In others, such as type 2 diabetes mellitus and cardiovascular disease, however, decreased estrogen production also appears to increase risk indirectly, by increasing adiposity [2,6-9].”
BackgroundLee, H. J., Hwang, S. Y., Hong, H. C., Ryu, J. Y., Seo, J. A., Kim, S. G., Kim, N. H., Choi, D. S., Baik, S. H., Choi, K. M., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2014.12.015 · Cited by 29
“[2] Carr MC.”
BackgroundInfluentialFu, X., XING, L., Xu, W., & Shu, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5236 · Cited by 29
“The marked decrease in ovarian secretion of estrogens that occurs around menopause has been hypothesized as a main cause of numerous diseases, including osteoporosis and stroke (1,2).”
Woo, Y. S., McIntyre, R. S., Kim, J.-B., Lee, M., Kim, J., Yim, H. W., & Jun, T. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.06.018 · Cited by 29
Klisic, A. N., Kotur‐Stevuljević, J., Kavarić, N., Martinović, M., & Matic, M. G. (2016) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-016-0325-1 · Cited by 29
“Menopause has been characterized by decreased estradiol levels and elevated follicle stimulating hormone (FSH), as well as changes in energy expenditure and body composition [1].”
BackgroundFactors associated with metabolic syndrome in a sample of women in Puerto Rico
Romaguera, J., Ortiz, A. P., Roca, F., Colón, G., & Suarez, E. L. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181bd5393 · Cited by 31
“The reduction in endogenous estrogens during the menopausal transition has been associated with insulin resistance, increased central adiposity, increased triglyceride and lowdensity lipoprotein cholesterol levels, and reduced HDL cholesterol level.(9,10) Together, these metabolic changes result in a higher incidence…”
BackgroundPhysical activity and cardiovascular risk factors at menopause: The Nord-Trøndelag health study
Guðmundsdóttir, S. L., Flanders, W. D., & Augestad, L. B. (2013) · Climacteric · doi:10.3109/13697137.2013.768231 · Cited by 32
Liu, H., Liu, L., & Rosen, C. J. (2025) · Current Obesity Reports · doi:10.1007/s13679-024-00594-9 · Cited by 30
“After age 50, coinciding with menopause, women experience accelerated marrow adiposity, exceeding 70% by age 80, compared to 60% in men [78, 79].”
Lin, C., Lin, Y., & Liu, C.-F. (2010) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x10008159 · Cited by 28
“Redistribution of body fat with increased visceral fat is believed to correlate with increased prevalence of metabolic syndrome, and consequently, cardiovascular disease in postmenopausal women (Park et al., 2003; Carr, 2003).”
BackgroundPang, J., Chen, K., Chen, S., & Chen, X. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00885-y · Cited by 28
“Estrogens have protective roles in the lipid metabolism and postmenopausal women are reported to develop metabolic disorder more easily [22, 23].”
BackgroundSardar, A., Gautam, S., Sinha, S., Rai, D., Tripathi, A. K., Dhaniya, G., Mishra, P. R., & Trivedi, R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121020 · Cited by 28
Karvinen, S. M., Korhonen, T.-M. K., Sievänen, T., Karppinen, J. E., Juppi, H., Jakoaho, V., Kujala, U. M., Laukkanen, J. A., Lehti, M., & Laakkonen, E. K. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12308 · Cited by 31
“Especially the decrease in systemic estrogen levels have been associated with unfavorable changes in metabolic health (Carr, 2003).”
BackgroundSu, X., Jin, K., Zhou, X. J., Zhang, Z., Zhang, C., Li, Y., Yang, M., Huang, X., Xu, S., Wei, Q., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1125819 · Cited by 32
Catalano, D., Trovato, G. M., Spadaro, D., Martines, G. F., Garufi, G., Tonzuso, A., Grasso, D., & Sciacchitano, S. (2008) · Climacteric · doi:10.1080/13697130802348728 · Cited by 29
Abedinzade, M., Nasri, S., Omidi, M. J., Ghasemi, E., & Ghorbani, A. (2015) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.26685 · Cited by 31
“Menopause is associated with increased risk of metabolic diseases such as type 2 diabetes and metabolic syndrome (1, 2).”
BackgroundLee, J. A., Yoo, J. E., & Park, H. S. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4131-x · Cited by 28
Estrada, C. M., Ghisays, V., Nguyen, E. T., Caldwell, J. L., Streicher, J., & Solomon, M. B. (2017) · Hormones and Behavior · doi:10.1016/j.yhbeh.2017.12.002 · Cited by 29
“Estrogens and especially estradiol (E2) have an important role in maintaining metabolic homeostasis and energy efficiency in both males and females, as well as in modulating mood in females (reviewed in Mauvais-Jarvis et al., 2013; Carr, 2003; Douma et al., 2005; Rogers et al., 2009).”
Distinct Hypothalamic Neurons Mediate Estrogenic Effects on Energy Homeostasis and Reproduction
Xu, Y., Nedungadi, T. P., Zhu, L., Sobhani, N. C., Irani, B. G., Davis, K. E., Zhang, X., Zou, F., Gent, L. M., Hahner, L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.04.006 · Cited by 29
The role of hypothalamic AMP-activated protein kinase in ovariectomy-induced obesity in rats
Tsai, Y.-C., Lee, Y., Lam, K., Wu, Y.-C., Yen, M., & Cheng, P. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181dfca27 · Cited by 28
“Postmenopausal women tend to gain body fat, which seems to be a consequence of the decline in endogenous estrogens.(6,7) In animal models, ovariectomy (Ovx) induces an increase in food intake and decreases ambulatory and wheel running activities, which is reversed with estrogen replacement.”
BackgroundPrasannarong, M., Saengsirisuwan, V., Piyachaturawat, P., & Suksamrarn, A. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-28 · Cited by 32
“These metabolic conditions in postmenopausal women are usually accompanied by weight gain, obesity, and increased inflammation [3-5].”
BackgroundKühl, H., & Stevenson, J. C. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600717368 · Cited by 29
“The rising proportion of postmenopausal women with the metabolic syndrome may partially explain the apparent acceleration in CVD after the menopause [14].”
BackgroundKim, S.-W., Cho, K.-H., Han, K., Roh, Y.-K., Song, I., & Kim, Y. (2016) · Medicine · doi:10.1097/md.0000000000003331 · Cited by 33
Yun, A. J., Lee, P. Y., & Bazar, K. A. (2003) · Medical Hypotheses · doi:10.1016/s0306-9877(03)00322-0 · Cited by 34
Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo
Powell, D. R. (2006) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00220.x · Cited by 31
Honarvar, M., Masoumi, S., Mehran, L., Khalili, D., Amouzegar, A., & Azizi, F. (2023) · Scientific Reports · doi:10.1038/s41598-023-33294-w · Cited by 29
Prática de atividade física e composição corporal em mulheres na menopausa
Buonani, C., Rosa, C. S. D. C., Diniz, T. A., Christófaro, D. G. D., Monteiro, H. L., Rossi, F. E., & Júnior, I. F. F. (2013) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032013000400004 · Cited by 46
Chen, S., Broquères-You, D., Yang, G., Wang, Z., Li, Y., Yang, F., & Tan, Y. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.12.001 · Cited by 30
“However, the protective effects of female sex hormones on metabolism conferred on women is not lifelong, which will dissipate rapidly after the age of 50 (Carr, 2003).”
BackgroundLópez, M., & Tena‐Sempere, M. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.08.004 · Cited by 29
Obesity at Menopause: An Expanding Problem
Atapattu, P. M. (2015) · Journal of Patient Care · doi:10.4172/2573-4598.1000103 · Cited by 30
“Visceral adiposity, measured by waist circumference is strongly associated with increased CVD risk in postmenopausal women [3,8,46].”
BackgroundMetabolic Syndrome and Associated Factors in Adults of the Amazon Region
França, S. L., Lima, S. S., & Vieira, J. R. D. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167320 · Cited by 30
“There have been indications of early menopausal signs in women from other Amazonian cities [26], and when menopause occurs, it is responsible for triggering negative changes in the cardiometabolic homeostasis of women, which promotes obesity, dyslipidemia, and other risk factors for MS, given the loss of cardiovascula…”
BackgroundYoon, J.-R., Ha, G.-C., Ko, K.-J., & Kang, S.-J. (2018) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1836446.223 · Cited by 33
“…the risk of metabolic syndrome, in which abdominal obesity and insulin resistance https://doi.org/10.12965/jer.1836446.223 Original Article Journal of Exercise Rehabilitation 2018;14(6):1032-1040 http://www.e-jer.org 1033https://doi.org/10.12965/jer.1836446.223 play important roles (Carr, 2003).”
BackgroundInfluentialZhao, Z., Fan, X., Gu, Y., Han, J., Jia, Y., Ye, K., & Zhang, Y. Q. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101149 · Cited by 29
“Unfortunately, following the onset of menopause, women are more vulnerable to developing metabolic-related chronic diseases, such as abdominal obesity, insulin resistance, and even T2D [9,10].”
BackgroundInfluentialLee, S. H., Kim, B., Choi, H. J., Cho, S. W., Shin, C. S., Park, S., Lee, Y., Lee, S., Kim, H., Kim, G. S., et al. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9584-7 · Cited by 29
“Rapidly increased weight gain after menopause is one of the underlying causes of associated diabetes mellitus, atherosclerosis, and metabolic syndrome [37].”
HDL-C in post-menopausal women: An important therapeutic target
Collins, P. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.06.009 · Cited by 28
Kwok, S., Selby, P. L., McElduff, P., Laing, I., Mackness, B., Mackness, M., Prais, H., Morgan, J., Yates, A. P., Durrington, P. N., et al. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02166.x · Cited by 27
“…menopause heralds a rising prevalence of central obesity, low levels of high density lipoprotein (HDL) cholesterol, high levels of low density lipoprotein (LDL) cholesterol and triglycerides, and insulin resistance: features of the metabolic syndrome that is strongly predictive of CHD (Carr, 2003).”
BackgroundJaff, N. G., Snyman, T., Norris, S. A., & Crowther, N. J. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000235 · Cited by 29
“Research shows that the menopausal transition (MT) is accompanied by clear physiological changes, some of which are temporary whereas others are long term.(2) The Study of Women Entering and in Endocrine Transition (SWEET) was developed to examine changes in metabolic, hormonal, and anthropometric parameters in black…”
BackgroundMenopause and Cardiovascular Risk
Bittner, V. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.02.032 · Cited by 32
Study of metabolic syndrome in postmenopausal women
Sapkota, A. S., Sapkota, A., Acharya, K., Raut, M., & Jha, B. (2015) · Annals of Clinical Chemistry and Laboratory Medicine · doi:10.3126/acclm.v1i1.12307 · Cited by 32
“A similar pattern of lipid abnormalities emerges with menopause [24].”
BackgroundSerum Acylated Ghrelin Is Negatively Correlated with the Insulin Resistance In the CODING study
Amini, P., Wadden, D., Cahill, F., Randell, E. W., Vasdev, S., Chen, X., Gulliver, W. P., Zhang, W., Zhang, H., Yi, Y., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045657 · Cited by 30
“In postmenopausal women, insulin resistance increases likely due to the reduced levels of sex hormones and physical activity and increased body fat [36,37,38].”
BackgroundImpact of estrogens on resting energy expenditure: A systematic review
Weidlinger, S., Winterberger, K., Pape, J., Weidlinger, M., Janka, H., von Wolff, M., & Stute, P. (2023) · Obesity Reviews · doi:10.1111/obr.13605 · Cited by 28
Centrally located body fat is related to appetitive hormones in healthy postmenopausal women.
Ritland, L., Alekel, D. L., Matvienko, O. A., Hanson, K. B., Stewart, J. W., Hanson, L. N., Reddy, M. B., Loan, M. D. V., & Genschel, U. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0836 · Cited by 28
“In particular, central adiposity in postmenopausal women is a major risk factor for developing insulin resistance (3), atherosclerotic cardiovascular disease (CVD) ( 4 ), dyslipidemia (5), hypertension (6), and breast cancer (7).”
BackgroundMurphy, M. O., Herald, J. B., Wills, C., Unfried, S. G., Cohn, D. M., & Loria, A. S. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00308.2016 · Cited by 27
“Reduced physiological levels of estrogens during menopause are well known to increase BMI and metabolic risk in clinical (9, 57) and experimental models (11, 20, 22, 60).”
BackgroundPonnusamy, S., Tran, Q. T., Thiyagarajan, T., Miller, D. D., Bridges, D., & Narayanan, R. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370216688569 · Cited by 26
Kim, M. H., Kim, E., Choi, Y. Y., Hong, J., & Yang, W. M. (2017) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x17500173 · Cited by 28
Comparison of transitional vs surgical menopause on monoamine and amino acid levels in the rat brain
Long, T., Yao, J. K., Li, J., Kirshner, Z. Z., Nelson, D., Dougherty, G. G., & Gibbs, R. B. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.05.003 · Cited by 26
“This appears at first to be contrary to clinical observations that the prevalence of the metabolic syndrome such as hyperglycemia increases with menopause [62].”
ResultBUTLER, M. J., & Eckel, L. A. (2018) · Integrative Zoology · doi:10.1111/1749-4877.12340 · Cited by 27
“Given that declining levels of estradiol in peri-menopausal women are associated with overeating and weight gain (Carr, 2003), it is important to investigate the mechanisms by which estradiol modulates the homeostatic and non-homeostatic controls of food intake, dietary choice, motivation to…”
BackgroundBuniam, J., Chukijrungroat, N., Khamphaya, T., Weerachayaphorn, J., & Saengsirisuwan, V. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00466.2018 · Cited by 26
Rios, J. S., Greenwood, E. A., Pavone, M. E., Cedars, M. I., Legro, R. S., Diamond, M. P., Santoro, N. F., Sun, F., Robinson, R. D., Christman, G. M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz012 · Cited by 27
Harraqui, K., Oudghiri, D. E., Hannoun, Z., Mrabti, H. N., Aboulaghras, S., Assaggaf, H. M., Rajab, B. S., Attar, A., Bouyahya, A., & Bour, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19106109 · Cited by 26
“), which explain the progressive increase in its incidence during the period of menopause [11,12].”
BackgroundFan, M. D., Maslow, B.-S. L., Santoro, N. F., & Schoenbaum, E. E. (2008) · Menopause international · doi:10.1258/mi.2008.008027 · Cited by 26
Farombi, E. O., Abolaji, A. O., Adedara, I., Maduako, I. C., & Omodanisi, E. I. (2014) · Human & Experimental Toxicology · doi:10.1177/0960327114532385 · Cited by 26
“The hormonal imbalance observed in this study is possibly due to the reported neurotoxic effect of artemisinin, since the female reproductive axis is regulated by the communication among the hypothalamus, pituitary, and the ovary.(57,58) The observed dose-dependent increase in progesterone level in all the artemisinin…”
BackgroundDayspring, T. D. (2011) · International Journal of Women s Health · doi:10.2147/ijwh.s16702 · Cited by 28
“Aging has also been shown to increase TG levels.(29) These TG increases are likely associated with insulin resistance related to age, menopausal status, weight increase, and obesity.”
Exercise improves cardiovascular control in a model of dislipidemia and menopause
Heeren, M. V., Sousa, L. E. D., Mostarda, C. T., Moreira, E. D., Machert, H., Rigatto, K., Wichi, R. B., Irigoyen, M. C., & Angelis, K. D. (2009) · Maturitas · doi:10.1016/j.maturitas.2008.12.011 · Cited by 25
“However, menopause has been ssociated with central obesity and metabolic syndrome developent [4], sympathetic overactivity [5], changes on lipid profile [6] nd endothelial dysfunction [7].”
BackgroundYun, S., Nguyen, H. D., Park, J., Oh, C., & Kim, M. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521001331 · Cited by 28
Acharya, K. D., Noh, H. L., Graham, M. E., Suk, S., Friedline, R. H., Gomez, C. C., Parakoyi, A. E. R., Chen, J., Kim, J. K., & Tetel, M. J. (2021) · Metabolites · doi:10.3390/metabo11080499 · Cited by 28
Traditional and Emerging Sex-Specific Risk Factors for Cardiovascular Disease in Women
Mehta, P. K., Gaignard, S. M., Schwartz, A. M., & Manson, J. E. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2308288 · Cited by 29
“Although there does not seem to be a correlation between the onset of menopause and higher glucose levels, an increased risk of metabolic syndrome emerges after the transition to menopause, beyond the risk attributable to age alone [34–36].”
BackgroundSmith, J. T., Reichenbach, A., Lemus, M. B., Mani, B. K., Zigman, J. M., & Andrews, Z. B. (2013) · Peptides · doi:10.1016/j.peptides.2013.06.012 · Cited by 28
Majumdar, A. S., Giri, P. R., & Pai, S. A. (2014) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000187 · Cited by 26
“The transformation from premenopause to postmenopause is accompanied by a predilection toward the development of metabolic syndrome.(46) Female rats become resistant to the development of insulin resistance and hypertension upon fructose feeding.”
BackgroundRizzo, M. R., Leo, S., FRANCISCIS, P. D., Colacurci, N., & Paolisso, G. (2013) · AGE · doi:10.1007/s11357-013-9554-7 · Cited by 25
“…post-menopause is associated with the emergence of many features of the metabolic syndrome, including an increased central body fat and blood pressure, a shift toward a more atherogenic lipid profile, and increased glucose and insulin levels with an increasing type 2 diabetes risk (Carr 2003).”
BackgroundAlvehus, M., Šimonytė, K., Andersson, T., Söderström, I., Burén, J., Rask, E., Mattsson, C., & Olsson, T. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04322.x · Cited by 26
Effects of ovariectomy and intrinsic aerobic capacity on tissue-specific insulin sensitivity
Park, Y.-M., Rector, R. S., Thyfault, J. P., Zidon, T. M., Padilla, J., Welly, R. J., Meers, G. M.-E., Morris, E. M., Britton, S. L., Koch, L. G., et al. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00434.2015 · Cited by 25
“This ovarian insufficiency leads to metabolic dysregulation, ultimately increasing risk for the development of type 2 diabetes (T2D) (3) and other cardiometabolic diseases to which postmenopausal women are particularly susceptible (5).”
BackgroundRodríguez-Cano, A. M., Mier‐Cabrera, J., Balas-Nakash, M., Muñoz‐Manrique, C., Legorreta-Legorreta, J., & Perichart‐Perera, O. (2015) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000400 · Cited by 30
“In a recent clinical trial, Perichart-Perera et al16 compared a structured hypocaloric diet with a behavioral therapy (BT) intervention in Mexican postmenopausal women with MetS.”
BackgroundInfluentialEffects of Hormone Therapy on Oxidative Stress in Postmenopausal Women with Metabolic Syndrome
Sánchez-Rodríguez, M. A., Zacarías-Flores, M., Castrejón-Delgado, L., Ruiz-Rodríguez, A. K., & Mendoza-Núñez, V. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091388 · Cited by 29
“In this regard, it has been reported that as a result of the decrease in estrogen level, an increase in abdominal adiposity and a decrease in energy expenditure occurs; this causes an increase in the cholesterol and TG concentration, in addition to a significant increase in glucose and insulin concentrations, which ma…”
BackgroundSales, M. C., de Oliveira, L. P., Cabral, N. L. D. A., de Sousa, S. E. S., Almeida, M. D. G., Lemos, T. M. A. M., Lyra, C. D. O., de Lima, K. C., Sena‐Evangelista, K. C. M., & Pedrosa, L. F. C. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.04.026 · Cited by 25
27-Hydroxycholesterol Promotes Adiposity and Mimics Adipogenic Diet-Induced Inflammatory Signaling
Asghari, A., Ishikawa, T., Hiramitsu, S., Lee, W.-R., Umetani, J., Bui, L., Korach, K. S., & Umetani, M. (2019) · Endocrinology · doi:10.1210/en.2019-00349 · Cited by 27
Park, J., Woo, H. W., Kim, M. K., Shin, J., Lee, Y. H., Shin, D. H., Shin, M., & Choi, B. Y. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02225-0 · Cited by 25
Legakis, I., Mantzouridis, T. D., Saramantis, A., & Lakka-Papadodima, E. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03346255 · Cited by 25
Metadata
- Authors
- Carr, M. C.
- Affiliations
- University of Washington (US)
- Corresponding author
- Carr, Molly C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2003-06
- Volume
- 88
- Issue
- 6
- Pages
- 2404-2411
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2123609879
- Cited by
- 1,449
- References
- 84
- Citations by year
- 2026: 54 · 2025: 64 · 2024: 55 · 2023: 67 · 2022: 69 · 2021: 69 · 2020: 65 · 2019: 67 · 2018: 86 · 2017: 61 · 2016: 97 · 2015: 91 · 2014: 79 · 2013: 84 · 2012: 86
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- metabolic syndrome, menopause, estrogen deficiency, ovarian failure, abdominal obesity, insulin resistance, dyslipidemia, cardiovascular risk, postmenopausal women, atherogenic lipid profile, small dense LDL, glucose metabolism
- MeSH terms
- Body Composition, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Prevalence, Metabolic Syndrome, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.